Cardiac wasting and cancer (2024) Markus S. Anker

Description

This viewpoint analyzes cardiac wasting associated with advanced cancer, proposing it as an important endpoint for cardio-oncology trials. It notes its high frequency (up to 50%) and significant clinical relevance, including reduced left ventricular size, increased mortality, and lower physical performance. The article calls for future research focusing on prevention, reversal, biomarker development, and differentiating cardiac cachexia from other chronic illnesses.